These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33616186)

  • 1. Leukocytoclastic Vasculitis in Cutaneous Crohn Disease in the Setting of COVID-19.
    Nassani N; Sweiss N; Berry JT; Calhoun C; Polick A; Trivedi I
    Inflamm Bowel Dis; 2021 May; 27(6):e74-e75. PubMed ID: 33616186
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythema elevatum diutinum and Crohn disease: a common pathogenic role for measles virus?
    Orteu CH; McGregor JM; Whittaker SJ; Balzola F; Wakefield AJ
    Arch Dermatol; 1996 Dec; 132(12):1523-5. PubMed ID: 8961895
    [No Abstract]   [Full Text] [Related]  

  • 3. Leukocytoclastic vasculitis secondary to COVID-19 infection presenting with inclusion bodies: A histopathological correlation.
    Yıldırım Bay E; Moustafa E; Semiz Y; Gündoğdu O; Oguz Topal I; Yalçın Ö
    J Cosmet Dermatol; 2022 Jan; 21(1):27-29. PubMed ID: 34846786
    [No Abstract]   [Full Text] [Related]  

  • 4. Leucocytoclastic vasculitis secondary to COVID-19 infection in a young child.
    Kumar G; Pillai S; Norwick P; Bukulmez H
    BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33827885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Leukocytoclastic vasculitis and acute renal failure following inactivated SARS-CoV-2 vaccine].
    Missoum S; Lahmar M; Khellaf G
    Nephrol Ther; 2022 Jul; 18(4):287-290. PubMed ID: 35074300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urticarial vasculitis: A potential signpost for multisystem inflammatory syndrome in children.
    Gosnell HL; Grider DJ
    J Cutan Pathol; 2022 Feb; 49(2):163-166. PubMed ID: 34523756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous leukocytoclastic vasculitis secondary to COVID-19 infection leading to extensive skin necrosis.
    Capoferri G; Daikeler T; Mühleisen B; Trendelenburg M; Müller S
    Clin Dermatol; 2022; 40(4):397-401. PubMed ID: 35248687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-onset cutaneous manifestations in a patient with severe COVID-19 infection.
    Mizutani Y; Nagai M; Tsuzuku A
    J Dermatol; 2020 Oct; 47(10):e347-e348. PubMed ID: 32725712
    [No Abstract]   [Full Text] [Related]  

  • 9. Extensive cutaneous leukocytoclastic vasculitis after Sinopharm vaccine: Case report and review of the literature.
    Azzazi Y; Abdelkader HA; Khedr H; El-Komy MHM
    J Cutan Pathol; 2022 Aug; 49(8):736-742. PubMed ID: 35355299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous small-vessel vasculitis following COVID-19 vaccine.
    Kar BR; Singh BS; Mohapatra L; Agrawal I
    J Cosmet Dermatol; 2021 Nov; 20(11):3382-3383. PubMed ID: 34529877
    [No Abstract]   [Full Text] [Related]  

  • 11. Leukocytoclastic vasculitis after exposure to COVID-19 vaccine.
    Fritzen M; Funchal GDG; Luiz MO; Durigon GS
    An Bras Dermatol; 2022; 97(1):118-121. PubMed ID: 34836739
    [No Abstract]   [Full Text] [Related]  

  • 12. Three cases of COVID-19 patients presenting with erythema.
    Tamai M; Maekawa A; Goto N; Ge L; Nishida T; Iwahashi H; Yokomi A
    J Dermatol; 2020 Oct; 47(10):1175-1178. PubMed ID: 32881072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocytoclastic vasculitis and necrolytic acral erythema in patients with hepatitis C infection: do viral load and viral genotype play a role?
    El-Darouti MA; Mashaly HM; El-Nabarawy E; Eissa AM; Abdel-Halim MR; Fawzi MM; El-Eishi NH; Tawfik SO; Zaki NS; Zidan AZ; Fawzi M; Abdelaziz M; Fawzi MM; Shaker OG
    J Am Acad Dermatol; 2010 Aug; 63(2):259-65. PubMed ID: 20462666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New-onset leukocytoclastic vasculitis after COVID-19 vaccine.
    Bostan E; Gulseren D; Gokoz O
    Int J Dermatol; 2021 Oct; 60(10):1305-1306. PubMed ID: 34241833
    [No Abstract]   [Full Text] [Related]  

  • 15. Leukocytoclastic vasculitis flare following the COVID-19 vaccine.
    Cohen SR; Prussick L; Kahn JS; Gao DX; Radfar A; Rosmarin D
    Int J Dermatol; 2021 Aug; 60(8):1032-1033. PubMed ID: 33928638
    [No Abstract]   [Full Text] [Related]  

  • 16. [Leukocytoclastic vasculitis secondary to vaccination against SARS-CoV-2].
    Martín Guerra JM; Moreta Rodríguez M
    Semergen; 2022; 48(5):e33-e34. PubMed ID: 35491375
    [No Abstract]   [Full Text] [Related]  

  • 17. Widespread cutaneous small vessel vasculitis secondary to COVID-19 infection.
    Tahir A; Sohail Z; Nasim B; Parmar NV
    Int J Dermatol; 2020 Oct; 59(10):1278-1279. PubMed ID: 32880974
    [No Abstract]   [Full Text] [Related]  

  • 18. Leukocytoclastic Vasculitis Related to Ustekinumab in a Crohn's Disease Patient: First Case Report and Literature Review.
    Costa-Moreira P; Lopes S; Santos AL; Pedrosa AF; Andrade P; Portugal R; Macedo G
    J Crohns Colitis; 2020 Feb; 14(2):274-276. PubMed ID: 31267125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 vaccine-induced urticarial vasculitis.
    Dash S; Behera B; Sethy M; Mishra J; Garg S
    Dermatol Ther; 2021 Sep; 34(5):e15093. PubMed ID: 34369046
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypersensitivity vasculitis with leukocytoclastic vasculitis secondary to infliximab.
    McIlwain L; Carter JD; Bin-Sagheer S; Vasey FB; Nord J
    J Clin Gastroenterol; 2003; 36(5):411-3. PubMed ID: 12702983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.